Jens Rueter, M.D.

Chief Medical Officer, JAX; Medical Director, MCGI

Rueter is the Chief Medical Officer of JAX, Medical Director of MCGI, and Associate Director for Translational Education at JAX Cancer Center. Rueter provides direction, leadership, and strategy for JAX’s translational and clinical research activities and clinically-oriented operations.

Jens Rueter, M.D. is the Chief Medical Officer of The Jackson Laboratory and Medical Director for the Maine Cancer Genomics Initiative. Rueter is a practicing hematologist/oncologist in Maine and has served as Medical Director for MCGI since its inception in 2016. In 2021, Rueter was named JAX’s first CMO and serves as the institution’s principal medical advisor.

Rueter came to JAX from Eastern Maine Medical Center Cancer Care (EMMC) in Brewer, Maine, where he was Medical Director for EMMC’s Translational Oncology Program and the EMMC Biobank. He has been on staff at Northern Light Eastern Maine Medical Center since 2010, and a member of the JAX adjunct faculty since 2012. Prior to joining JAX, Rueter collaborated with several JAX investigators and technicians on developing new approaches to treating cancers while advancing translational research at EMMC. After graduating from medical school in Berlin, Germany, Rueter completed his residency in internal medicine at Tulane University and fellowship training in hematology/oncology at the University of Pennsylvania.